Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (361-370 of 451) with videos related to

Pageof 46
Sort By:
Journal of Viral Hepatitis|October 15, 2013
The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infectionA J van der Meer, B J Veldt, J J Feld, et al.
Hepatology (Baltimore, Md.)|May 1, 2023
Pathway to global elimination of hepatitis B: HBV cure is just the first stepJessica Howell, Chris Seaman, Jack Wallace, et al.
Journal of Viral Hepatitis|December 24, 2017
Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infectionM S Sulkowski, J J Feld, E Lawitz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2016
Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and CirrhosisRaoel Maan, Marjolein van Tilborg, Katja Deterding, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2024
Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical TrialsEdo J Dongelmans, Jordan J Feld, André Boonstra, et al.
Gastroenterology|March 23, 2010
Ribavirin improves early responses to peginterferon through improved interferon signalingJordan J Feld, Glen A Lutchman, Theo Heller, et al.
Journal of Gastroenterology and Hepatology|December 10, 2015
Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosisAdriaan J van der Meer, Raoel Maan, Bart J Veldt, et al.
The New England Journal of Medicine|December 31, 2010
Residual NADPH oxidase and survival in chronic granulomatous diseaseDouglas B Kuhns, W Gregory Alvord, Theo Heller, et al.
Journal of the International AIDS Society|September 7, 2023
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT studyJoanne M Carson, Sebastiano Barbieri, Evan Cunningham, et al.
Viruses|September 7, 2019
Hepatitis C Core-Antigen Testing from Dried Blood SpotsMia J Biondi, Marjolein van Tilborg, David Smookler, et al.
Pageof 46

Showing results (361-370 of 451) with videos related to

Sort By:
Pageof 46
Journal of Viral Hepatitis|October 15, 2013
The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infectionA J van der Meer, B J Veldt, J J Feld, et al.
Hepatology (Baltimore, Md.)|May 1, 2023
Pathway to global elimination of hepatitis B: HBV cure is just the first stepJessica Howell, Chris Seaman, Jack Wallace, et al.
Journal of Viral Hepatitis|December 24, 2017
Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infectionM S Sulkowski, J J Feld, E Lawitz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2016
Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and CirrhosisRaoel Maan, Marjolein van Tilborg, Katja Deterding, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2024
Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical TrialsEdo J Dongelmans, Jordan J Feld, André Boonstra, et al.
Gastroenterology|March 23, 2010
Ribavirin improves early responses to peginterferon through improved interferon signalingJordan J Feld, Glen A Lutchman, Theo Heller, et al.
Journal of Gastroenterology and Hepatology|December 10, 2015
Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosisAdriaan J van der Meer, Raoel Maan, Bart J Veldt, et al.
The New England Journal of Medicine|December 31, 2010
Residual NADPH oxidase and survival in chronic granulomatous diseaseDouglas B Kuhns, W Gregory Alvord, Theo Heller, et al.
Journal of the International AIDS Society|September 7, 2023
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT studyJoanne M Carson, Sebastiano Barbieri, Evan Cunningham, et al.
Viruses|September 7, 2019
Hepatitis C Core-Antigen Testing from Dried Blood SpotsMia J Biondi, Marjolein van Tilborg, David Smookler, et al.
Pageof 46